Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2425 of 3173 entries
View as:

Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02192164 Org: User:
Start: 11/30/13 End: 05/31/16 Due: 05/31/17

PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT00614705 Org: User:
Start: 04/30/08 End: 12/31/08 Due: 12/31/09

Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO

Phase: N/A Priority: Normal
NCT ID: NCT01959919 Org: User:
Start: 01/27/14 End: 12/12/16 Due: 12/12/17

Tanezumab in Osteoarthritis Of The Hip

Phase: N/A Priority: Normal
NCT ID: NCT00744471 Org: User:
Start: 11/17/08 End: 08/13/10 Due: 08/13/11

A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib (PD-0332991) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women of Non-Childbearing Potential.

Phase: N/A Priority: Normal
NCT ID: NCT01756781 Org: User:
Start: 05/31/13 End: 07/31/13 Due: 07/31/14

Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT00886743 Org: User:
Start: 09/30/09 End: 12/31/15 Due: 12/31/16

Phase I Safety, Pharmacokinetics and Bioavailability Study Comparing Rate and Extent of Absorption of Two Different Forms of Tafamidis (PF-6291826)

Phase: N/A Priority: Normal
NCT ID: NCT03662191 Org: User:
Start: 09/28/18 End: 01/10/19 Due: 01/10/20

A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02208284 Org: User:
Start: 08/31/14 End: 12/31/14 Due: 12/31/15

Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH

Phase: N/A Priority: Normal
NCT ID: NCT00706537 Org: User:
Start: 07/31/08 End: 11/30/08 Due: 11/30/09

A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03715829 Org: User:
Start: 11/26/18 End: 02/05/21 Due: 02/05/22

Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008

Phase: N/A Priority: Normal
NCT ID: NCT01903733 Org: User:
Start: 08/28/13 End: 06/05/20 Due: 06/05/21

A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT01298544 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00644176 Org: User:
Start: 11/30/04 End: 04/30/05 Due: 04/30/06

A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06347861 Org: User:
Start: 04/02/24 End: 08/08/24 Due: 08/08/25

Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03233529 Org: User:
Start: 07/31/17 End: 05/04/18 Due: 05/04/19

A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00875030 Org: User:
Start: 06/30/09 End: 06/30/09 Due: 06/30/10

Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT04408794 Org: User:
Start: 06/29/20 End: 12/23/21 Due: 12/23/22

Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01221935 Org: User:
Start: 09/30/09 End: 01/31/10 Due: 01/31/11

PF-06651600 Taste Study.

Phase: N/A Priority: Normal
NCT ID: NCT03916393 Org: User:
Start: 04/15/19 End: 05/10/19 Due: 05/10/20

Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.

Phase: N/A Priority: Normal
NCT ID: NCT00658684 Org: User:
Start: 02/29/08 End: 08/31/09 Due: 08/31/10

Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT00147498 Org: User:
Start: 01/31/05 End: 06/30/06 Due: 06/30/07

Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033

Phase: N/A Priority: Normal
NCT ID: NCT00376285 Org: User:
Start: 11/30/06 End: - Due: -

Immunization To Prevent Acute COPD Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT03276754 Org: User:
Start: 11/30/17 End: 06/16/22 Due: 06/16/23

A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01002963 Org: User:
Start: 09/30/09 End: 02/28/10 Due: 02/28/11

Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity

Phase: N/A Priority: Normal
NCT ID: NCT00367783 Org: User:
Start: 06/30/06 End: 04/30/07 Due: 04/30/08